In other rodent models, neuroinflammation caused by LPS and stroke was lowered with glycyrrhizin treatment by reducing HMGB1-mediated TLR4-NF-κB activation (Kim et al., 2012; Barakat et al., 2014; Sun et al., 2018). The gene discussed is NFKB1; the disease is stroke disorder.